美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=SULAR
符合检索条件的记录共8
1 页 当前第 1 页  返回检索页
1药品名称SULAR
申请号020356产品号001
活性成分NISOLDIPINE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1995/02/02申请机构SHIONOGI INC
2药品名称SULAR
申请号020356产品号002
活性成分NISOLDIPINE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1995/02/02申请机构SHIONOGI INC
3药品名称SULAR
申请号020356产品号003
活性成分NISOLDIPINE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格30MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1995/02/02申请机构SHIONOGI INC
4药品名称SULAR
申请号020356产品号004
活性成分NISOLDIPINE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1995/02/02申请机构SHIONOGI INC
5药品名称SULAR
申请号020356产品号005
活性成分NISOLDIPINE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格34MG
治疗等效代码AB参比药物
批准日期2008/01/02申请机构SHIONOGI INC
6药品名称SULAR
申请号020356产品号006
活性成分NISOLDIPINE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2008/01/02申请机构SHIONOGI INC
7药品名称SULAR
申请号020356产品号007
活性成分NISOLDIPINE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格17MG
治疗等效代码AB参比药物
批准日期2008/01/02申请机构SHIONOGI INC
8药品名称SULAR
申请号020356产品号008
活性成分NISOLDIPINE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格8.5MG
治疗等效代码AB参比药物
批准日期2008/01/02申请机构SHIONOGI INC